GOVX Stock, GeoVax Labs Inc. Information

GeoVax Labs, Inc. is a clinical stage biotechnology company developing human vaccines against infectious diseases using our Modified Vaccinia Ankara Virus Like Particle MVA VLP vaccine platform. Our current development programs are focused on preventive vaccines against HIV, Zika virus, Hemorrhagic Fever viruses Ebola, Sudan, Marburg, Lassa , and malaria, as well as therapeutic vaccines for chronic Hepatitis B infections and cancers. Our vaccine platform supports in vivo production of non infectious VLPs in the person receiving the vaccine. The production of VLPs in the person being vaccinated mimics virus production in a natural infection, stimulating both the humoral and cellular arms of the ijmmune system to recognize, prevent, and control the target infection.